From crystal structure prediction to totally empirical screening, the quest for new crystal forms has become one of the most challenging issues in the solid state science and particularly in the pharmaceutical world. In this context, multi-component crystalline materials like co-crystals have received renewed interest as they offer the prospect of optimized physical properties. As illustrated in this first book_ entirely dedicated to this emerging class of pharmaceutical compounds_ the outcome of such endeavours into crystal engineering have demonstrated clear impacts on production, marketing and intellectual property protection of active pharmaceutical ingredients (APIs). Indeed, co-crystallization influences relevant physico-chemical parameters (such as solubility, dissolution rate, chemical stability, melting point, hygroscopicity, à) and often offers solids with properties superior to those of the free drug. Combining both reports of the latest research and comprehensive overviews of basic principles, with contributions from selected experts in both academia and industry, this unique book is an essential reference, ideal for pharmaceutical development scientists and graduate students in pharmaceutical science.
Płać wygodnie kartą, Klarną, Apple Pay lub Google Pay. Nie jesteś zadowolony? Zawsze masz 14-dniową gwarancję zwrotu pieniędzy. Więcej przeczytasz w naszych warunkach. Masz pytania? Napisz do nas na hello@memmo.org.
Memmo ułatwia naukę – gdziekolwiek jesteś na świecie. U nas znajdziesz podręczniki i sprytne narzędzia do nauki w jednym miejscu: streszczenia, quizy, podcasty i fiszki. A do tego Ted, Twój kumpel do nauki, który odpowie na wszystko, co Cię nurtuje. Ponad 50 000 studentów już tu się uczy – stworzone, byś uczył się szybciej i mniej stresował.